IN VITRO DIAGNOSTICS Agendia BV Agendia raises $65mm through late-stage round A year after withdrawing its IPO filing, molecular diagnostics firm Agendia BV has raised $65mm in what appears to
Each year, START-UP reviews the sectors of the medical device industry that received private funding to see what will be filling the pipelines of medical device companies in the future. Despite gloo